17 search results for: lung function

Type 2 Inflammation and Airway Remodeling Drive <b>Lung</b> <b>Function</b> Decline
Pulmonology
Type 2 Inflammation and Airway Remodeling Drive Lung Function Decline
videoanimation

Explore the impact of type 2 inflammation and airway remodeling on lung function decline in asthma.

View more
Why Is It Important to Assess <b>Lung</b> <b>Function</b> in Pediatric Asthma?
Pulmonology
Why Is It Important to Assess Lung Function in Pediatric Asthma?
interactivity

Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma.

View more
Monitoring <b>Lung</b> <b>Function</b> Is an Important Aspect of Pediatric Asthma Management
Pulmonology
Monitoring Lung Function Is an Important Aspect of Pediatric Asthma Management
interactivity

Navigate through this interactive infographic to learn more about why lung function is important to monitor in pediatric patients with asthma and the noninvasive procedures that are available for implementation in clinical practice.

View more
ADVENT On Air | Breathing Easy: Navigating <b>Lung</b> <b>Function</b> in Pediatric Severe Asthma With Spirometry and Beyond
Pulmonology
ADVENT On Air | Breathing Easy: Navigating Lung Function in Pediatric Severe Asthma With Spirometry and Beyond
Podcast

Join Drs. Wanda Phipatanakul and Theresa Guilbert as they discuss the importance of routine lung function assessment in pediatric asthma patients.

View more
The Cycle of Inflammation in Adult Asthma
Pulmonology
The Cycle of Inflammation in Adult Asthma
interactivity

Explore the role of chronic type 2 inflammation in the cycle of exacerbations and worsening lung function in patients with asthma.

View more
Clinical Manifestations Associated With Airway Remodeling in Asthma
Type 2 Inflammation
Clinical Manifestations Associated With Airway Remodeling in Asthma
expert video

Join Dr. Hanania to understand how to identify patients at risk of fixed airway obstruction in clinical settings.

View more
Mucus Plugging as a Potential Target in Asthma Management
Type 2 Inflammation
Mucus Plugging as a Potential Target in Asthma Management
expert video

Join Dr. Celeste Porsbjerg as she explores the mechanisms underlying mucus plugging development as mucociliary clearance. She explains how type 2 cytokines—particularly IL-13—impair this clearance mechanism, leading to mucus plugging, and worsened asthma outcomes.

View more
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Pulmonology
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Infographic

Learn how FeNO, a noninvasive biomarker for type 2 inflammation, can be used to optimize care for asthma patients.

View more
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
Pulmonology
Type 2 Inflammation Mediates Severe Asthma in Pediatric Patients
expert video

Dr. Leonard Bacharier discusses how type 2 inflammation underlies the pathophysiology of pediatric severe asthma and contributes to burden.

View more
Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
Pulmonology
Airway Remodeling in Type 2 Asthma is Driven by IL-4 and IL-13
expert video

Dr. Reynold Panettieri discusses how IL-4 and IL-13 drive airway remodeling in type 2 asthma.

View more
Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma
Type 2 Inflammation
Unraveling the Link of Type 2 Inflammation and Airway Remodeling in Asthma
expert video

Join Dr. Celeste Porsbjerg as she discussed on how type 2 inflammation may lead to airway remodeling in asthma, exploring the pathophysiologic mechanisms, that ultimately lead to structural changes and irreversible loss of lung function

View more
ERS 2025 Enduring Video: Type 2 Severe Asthma “Unplugged”: Reducing Mucus to Improve Long- Term Patient Outcomes
On Demand
ERS 2025 Enduring Video: Type 2 Severe Asthma “Unplugged”: Reducing Mucus to Improve Long- Term Patient Outcomes

Join Drs. Njira Lugogo, Simon Couillard, and Mario Castro for a session exploring the link between pathogenic mucus and impaired lung function in patients with moderate-to-severe asthma and the potential for disease modification with targeted therapy.